Literature DB >> 30668883

Short Versus Long Cephalomedullary Nails for Fixation of Stable Versus Unstable Intertrochanteric Femur Fractures at a Level 1 Trauma Center.

D Andrew Hulet, Casey S Whale, Michael J Beebe, David L Rothberg, Jeremy M Gililland, Chong Zhang, Angela P Presson, Ami R Stuart, Erik N Kubiak.   

Abstract

The purpose of this study was to compare failure and complication rates associated with short cephalomedullary nail vs long cephalomedullary nail fixation for stable vs unstable intertrochanteric femur fractures. This study included 201 adult patients with nonpathologic intertrochanteric femur fractures without subtrochanteric extension (OTA 31-A1.1-3, 31-A2.1-3, 31-A3.1-3) who were treated with a short cephalomedullary nail (n=70) or a long cephalomedullary nail (n=131) and had at least 6 months of follow-up. Treatment groups were similar in terms of age, sex, and comorbidities. In the stable fracture group (N=81), there was no difference in total complications (adjusted P=.73), failure (adjusted P=.78), or mortality (adjusted P=.62) between short cephalomedullary nails and long cephalomedullary nails. Unstable fracture patterns were more likely to be treated with a long cephalomedullary nail than a short cephalomedullary nail (P=.01). In the unstable fracture group (N=120), there was no difference in total complications (adjusted P=.32) or failure (adjusted P=.31) between short cephalomedullary nails and long cephalomedullary nails. A cumulative mortality curve showed a trend toward increasing mortality in unstable fractures treated with short cephalomedullary nails. Traumatologists did not display a statistically significant preference between short cephalomedullary nails and long cephalomedullary nails when compared with nontraumatologists. [Orthopedics. 2019; 42(2):e202-e209.]. Copyright 2019, SLACK Incorporated.

Entities:  

Mesh:

Year:  2019        PMID: 30668883     DOI: 10.3928/01477447-20190118-03

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

1.  How are peri-implant fractures below short versus long cephalomedullary nails different?

Authors:  L Henry Goodnough; Brett P Salazar; Jamie Furness; James E Feng; Malcolm R DeBaun; Sean T Campbell; Justin F Lucas; William W Cross; Philipp Leucht; Kevin D Grant; Michael J Gardner; Julius A Bishop
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-09

2.  Failure of short versus long cephalomedullary nail after intertrochanteric fractures.

Authors:  Pernille Engell Bovbjerg; Morten Schultz Larsen; Carsten Fladmose Madsen; Jesper Schønnemann
Journal:  J Orthop       Date:  2019-11-06

3.  Treatment of Intertrochanteric Femur Fractures with Long versus Short Cephalomedullary Nails.

Authors:  Cameron Sadeghi; Heather A Prentice; Kanu M Okike; Elizabeth W Paxton
Journal:  Perm J       Date:  2020

4.  Clinical Outcomes of Intermediate-Length Cephalomedullary Nails for Intertrochanteric Femur Fracture Repair in Older Adults.

Authors:  Paul A Enns; Sue M Nyberg; Gina M Berg; Morgan A Galliart; Brent D Sarauer; Andrew A Scheer; Bradley R Dart; Chad M Corrigan
Journal:  Kans J Med       Date:  2020-05-21

5.  Clinical outcomes following long versus short cephalomedullary devices for fixation of extracapsular hip fractures: a systematic review and meta-analysis.

Authors:  Gabriel Kai Yang Tan; Christoph Sheng Chong; Hamid Rahmatullah Bin Abd Razak
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

6.  Sub-Classification of AO/OTA-2018 Pertrochanteric Fractures Is Associated With Clinical Outcomes After Fixation of Intramedullary Nails.

Authors:  Hui Song; Sun-Jun Hu; Shou-Chao Du; Wen-Feng Xiong; Shi-Min Chang
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-11-23

7.  Tips and tricks to avoid implant failure in proximal femur fractures treated with cephalomedullary nails: a review of the literature.

Authors:  Joseph L Petfield; Luke E Visscher; Boyko Gueorguiev; Karl Stoffel; Hans-Christoph Pape
Journal:  OTA Int       Date:  2022-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.